CancerCare is a leading national organization dedicated to providing free support services and financial assistance to anyone affected by cancer. 800-813-HOPE
Last year, @CancerCare provided 150,508 services to people diagnosed with cancer, caregivers and bereaved individuals. Our emotional, practical and financial support programs continued to offer help and hope to anyone affected by cancer.
Learn more at https://t.co/EGLy4PRLa1.
Support can look different for every head and neck cancer (HNC) and thyroid cancer (TC) patient, and caregivers are often a vital part of their journey. If you or someone you know is caring for someone with HNC or TC, here are resources that may help: https://t.co/V1SAy3t798
#ad
Mealtime has meaning – it can provide nourishment and moments of connection. But mealtime can feel different after a head and neck cancer (HNC) or thyroid cancer (TC) diagnosis. For stories and recipes from HNC and TC survivors, visit: https://t.co/MmHlra6SFV
#ad
Cancer Support Community is joined by other cancer advocacy organizations in strongly opposing provisions in the CMS interim final rule.
See our joint statement here: https://t.co/BIOZiCWy9C
The @US_FDA has approved capivasterib plus abiraterone and prednisone for patients with PTEN- deficient metastatic hormone-sensitive prostate cancer. #pcsm | @FDAOncology
https://t.co/bHTAe5u3m0
Finding platinum-resistant #ovariancancer and #endometrialcancer clinical trials can feel overwhelming. Our trial finder supports people with cancer as they explore potential study options, such as the BEHOLD-1 study. Learn more: https://t.co/e8pOXO92aq
#CancerCare#ClinicalTrial
During this edition of #AntibodyHour 🕙, hear from Vilmarie Rodriguez, VP of Patient Assistance & Community Engagement at @CancerCare who shares about Cancer Care’s work in developing programs for patients through counseling, support groups and patient advocacy. She shares how she has found purpose in helping others.
Her mission inspires us at Genmab as we move with the ambition to transform the lives of people living with cancer through innovative antibody medicines.
#PatientFirst
Health insurance barriers are disrupting the lives of people with cancer. CancerCare has been listening – and now it’s time to act.
Join us on June 17 for the Micro Insights, Macro Impact webinar.
Register here: https://t.co/i17HkOsuFY
#HealthcarePolicy#PatientAdvocacy
Neeta Somaiah, MD, gave her perspective on GIST clinical trials in myTRIAList’s INSIGHT study overview video. Keep up to date on the latest trial-overview videos in @CancerCare's myTRIAList Trial Finder here: https://t.co/wuEKqmZqlt
#GISTawareness#cancerresearch#oncologist#MD